Test your basic knowledge |

First Aid Basics

Subjects : health-sciences, first-aid

Instructions:

Answer 50 questions in 15 minutes.
If you are not ready to take this test, you can study here.
Match each statement with the correct term.
Don't refresh. All questions and answers are randomly picked and ordered every time you load a test.

This is a study tool. The 3 wrong answers for each question are randomly chosen from answers to other questions. So, you might find at times the answers obvious, but you will see it re-enforces your understanding as you take the test each time.

1. Mature teratoma in men or malignant teratoma in M/F
Red (hemorrhagic) infarcts
DCC gene
malignant >1 cell type tumor
p53 gene

2. Secondary osteosarcoma and fibrosarcoma

3. ADH
Chronic inflammatory mediators
bcl -2 gene
paraneoplastic effects of small cell lung carcinoma and intracranial neoplasms
CEA

4. Tumor marker: neuroblastoma - lung and gastric cancer
Bombesin
skeletal muscle benign tumor
Primary tumors that met to brain
Leukocyte extravasation: migration

5. Tumor marker: pancreatic adenocarcinoma
CA-19-9
Rb gene
calcitonin
Reversible - plasias

6. Female 13%/23% and rising Male 16%/33% (mortality has plateaued)
benign >1 cell type tumor
radiation exposure
TRAP
lung cancer incidence/mortality

7. GIST cytokine receptor (oncogene)
c - kit gene
Alkylating agents target
skeletal muscle benign tumor
malignant epithelial tumor

8. Anaplasia - neoplasia - desmoplasia (fibrous tissue formation in response to neoplasm)
Irreversible - plasias
ret gene
cirrosis (alcohol - hepB or C)
Acute inflammatory mediators

9. MEN type II and III tyrosine kinase (oncogene)
AIDS
ret gene
Alk - phos
calcitonin

10. Prostate (blastic) - thyroid - testes - breast (lytic and blastic) - lung (lytic) - kidney (breast and prostate are most common)
paraneoplastic effects of thymoma - small cell lung carcinoma
paraneoplastic effects of leukemias and lymphomas
intrinsic apoptosis
Primary tumors that met to bone

11. PTH- related peptide - TGF- beta - TNF - IL-1
NF1 gene
paraneoplastic effects of SqC lung carcinoma - renal cell carcinoma and breast carcinoma.
Napthalene (aniline) dyes target
Primary tumors that met to brain

12. Rhabdomyosarcoma
skeletal muscle malignant tumor
BRCA1 gene
benign epithelial tumor
iron poisoning

13. Colon cancer (Deleted in Colon Cancer) 18q tumor suppressor
DCC gene
TRAP
Necrosis
Chronic inflammatory mediators

14. Malignant melanoma
erb - B2 gene
beta - hCG
dysplastic nevus
blood vessels malignant tumor

15. Squamous cell carcinoma of the esophagus
TRAP
Plummer - Vinson syndrome (atrophic glossitis - esophageal webs - anemia)
AIDS
primary amyloidosis

16. Retinoblastoma - osteosarcoma 13q tumor suppressor (blocks G1 to S phase progression)
TRAP
Rb gene
Resolution of inflammation
lung cancer incidence/mortality

17. Tumor marker: mets to bone - obstructive biliary disease - Paget's
skeletal muscle benign tumor
Alk - phos
CCl4 target
fat benign tumor

18. Leiomyoma
lung cancer incidence/mortality
smooth muscle benign tumor
CCl4 target
c - kit gene

19. All - AML
Neoplasm associated with Down Syndrome
Colon and rectal cancer incidence
Second - leading cause of death in the US
malignant epithelial tumor

20. Tumor marker: Screen for prostate carcinoma. Can also be elevated in BPH and prostatitis.
PSA
BRAC2 gene
paraneoplastic effects of SqC lung carcinoma - renal cell carcinoma and breast carcinoma.
NF2 gene

21. Vascular: E and P- selectin Leukocyte: Sialyl Lewis
Free radical eliminators
Leukocyte extravasation: rolling
prostate cancer incidence/mortality
Colon and rectal cancer incidence

22. Sarcoma - papillary thyroid cancer
Plummer - Vinson syndrome (atrophic glossitis - esophageal webs - anemia)
CA-125
radiation exposure
p53 gene

23. Tumor marker: melanoma - neural tumors - astrocytomas
CA-125
benign >1 cell type tumor
Neoplasm associated with tuberous sclerosis (facial angiofibroma - seizures - mental retardation)
S-100

24. Antibodies to presynaptic Ca2+ channels at NM junction
nitrosamines (smoked foods) target
paraneoplastic effects of renal cell carcinoma - hemangioblastoma
paraneoplastic effects of leukemias and lymphomas
paraneoplastic effects of thymoma - small cell lung carcinoma

25. Hyperuricemia (excess NA turnover)
paraneoplastic effects of leukemias and lymphomas
paraneoplastic effects of small cell lung carcinoma
causes of decreased ESR
primary amyloidosis

26. Lung tumor transcription factor (oncogene)
L- myc gene
Leukocyte extravasation: rolling
abl gene
paraneoplastic effects of renal cell carcinoma - hemangioblastoma

27. Lymphoma

28. Melanoma 9p tumor suppressor
Bombesin
arsenic target
p16 gene
Primary tumors that met to brain

29. Burkitt's lymphoma transcription factor (oncogene)
c - myc gene
cigarette smoke target
CA-19-9
NF2 gene

30. Astrocytoma - angiomyolipoma - cardiac rhabdomyoma
asbestos target
granulomatous disease
Neoplasm associated with tuberous sclerosis (facial angiofibroma - seizures - mental retardation)
abl gene

31. Tumor marker: (Normal in fetus). Hepatocellular carcinomas. Nonseminomatous germ cell tumors of the testis.
c - kit gene
DPC gene
paraneoplastic effects of thymoma - small cell lung carcinoma
alpha - fetoprotein

32. Colorectal cancer (assoc with FAP) 5q tumor suppressor
extrinsic apoptosis
APC gene
Leukocyte extravasation: migration
p16 gene

33. Erythropoietin
paraneoplastic effects of renal cell carcinoma - hemangioblastoma
Irreversible - plasias
Red (hemorrhagic) infarcts
Bombesin

34. Tumor marker: Hydatifiform moles - choriocarcinomas - gestational trophoblastic tumors.
Napthalene (aniline) dyes target
beta - hCG
bcl -2 gene
calcitonin

35. Neurofibromatosis type 1 17q tumor suppressor
NF2 gene
iron poisoning
NF1 gene
Leukocyte extravasation: rolling

36. Breast cancer 13q tumor suppressor (DNA repair protein)
skeletal muscle benign tumor
causes of decreased ESR
BRAC2 gene
smooth muscle malignant tumor

37. Esophagus - stomach
nitrosamines (smoked foods) target
L- myc gene
BRAC2 gene
Leukocyte extravasation: tight binding

38. Adenoma - papilloma
vinyl chloride target
benign epithelial tumor
Rb gene
secondary amyloidosis (reactive systemic)

39. 32%/13% male
prostate cancer incidence/mortality
fat malignant tumor
c - kit gene
malignant mesenchyme tumor (general)

40. Most human cancers - specifically Li - Fraumeni syndrome 17p tumor suppressor (blocks G1 to S phase progression)
CEA
p53 gene
DPC gene
bcl -2 gene

41. Liposarcoma
paraneoplastic effects of small cell lung carcinoma
Neoplasm associated with Down Syndrome
Autoimmune (Hashimoto's - myasthenia gravis)
fat malignant tumor

42. Malignant lymphoma
malignant >1 cell type tumor
immunodeficiency states
Chronic inflammatory mediators
DPC gene

43. Osteoma
bone benign tumor
Reversible - plasias
aflatoxin target
p53 gene

44. Leiomyosarcoma
Leukocyte extravasation: migration
CA-19-9
smooth muscle malignant tumor
Pale infarcts

45. Neutrophils (eos in the gut) - plus other granular leukocytes and antibodies.
bcl -2 gene
Alk - phos
Acute inflammatory mediators
paraneoplastic effects of renal cell carcinoma - hemangioblastoma

46. Pancreatic cancer (Deleted in Pancreatic Cancer) 18q tumor suppressor
DPC gene
smooth muscle malignant tumor
Resolution of inflammation
fat benign tumor

47. Tumor marker: prostate carcinoma marker.
NF1 gene
Prostatic acid phosphatase
prostate cancer incidence/mortality
Neoplasm associated with xeroderma pigmentosum (albinism)

48. 32%/18% female
Alkylating agents target
S-100
fat malignant tumor
breast cancer incidence/mortality

49. Membrane lipid peroxidation - protein modification and DNA breakage.
Acute inflammatory mediators
Necrosis
p53 gene
Free radical cell damage

50. Lung - liver - intestine or following reperfusion.
alpha - fetoprotein
smooth muscle malignant tumor
benign >1 cell type tumor
Red (hemorrhagic) infarcts